^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Prostate Cancer |
| Drug: | mitoxantrone (Topoisomerase II inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Prostate Cancer: Preferred regimens...Listed useful under certain circumstances regimens…Mitoxantrone for palliation in symptomatic patients with visceral metastases who cannot tolerate other therapies.
